Valneva SE (INRLF) Financials

INRLF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 442.5 million 350.0 million
March 31, 2026 427.9 million 339.7 million
Dec. 31, 2025 468.2 million 343.6 million
Sept. 30, 2025 526.0 million 349.4 million

INRLF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -21.0 million ?
March 31, 2026 -5.4 million ?
Dec. 31, 2025 -30.0 million ?
Sept. 30, 2025 -21.3 million ?

INRLF Net Income

No data available :(

INRLF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 138.5 million - -
March 31, 2026 121.1 million - 31.1 million
Dec. 31, 2025 128.7 million - 33.0 million
Sept. 30, 2025 168.4 million - 33.0 million

INRLF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 216.4 million
March 31, 2026 197.2 million
Dec. 31, 2025 203.6 million
Sept. 30, 2025 180.6 million

INRLF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 389731 17.1 million - -
March 31, 2026 284126 17.5 million 9.4 million 8.0 million
Dec. 31, 2025 1.3 million 30.0 million 9.2 million 10.3 million
Sept. 30, 2025 783917 32.0 million 12.3 million 9.7 million

INRLF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 39.8 million 38.0 million
March 31, 2026 35.5 million 30.1 million
Dec. 31, 2025 56.0 million 42.3 million
Sept. 30, 2025 34.5 million 28.1 million

INRLF

Price: $3.45

52 week price:
2.43
6.28

Earnings Per Share: -1.04 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 654.3 million

Links: